Harmon Cyrus (CIK 1831410) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-27). Recent activity: Sell OLMA (12,500 shares), Sell OLMA (12,500 shares), Sell OLMA (10,000 shares), Sell OLMA (3,489 shares), Sell OLMA (2,881 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-27 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Sell | 12,500 | $144,738 |
| 2026-07-27 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Sell | 12,500 | $146,425 |
| 2026-01-21 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Sell | 10,000 | $268,800 |
| 2026-01-16 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Sell | 3,489 | $101,600 |
| 2025-12-29 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Sell | 2,881 | $82,195 |
| 2025-09-18 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Sell | 10,000 | $80,400 |
| 2025-09-18 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Sell | 10,000 | $83,300 |
| 2025-09-18 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Sell | 1,914 | $15,465 |
| 2025-09-18 | Olema Pharmaceuticals, Inc. (OLMA) | Director | Sell | 3,086 | $25,676 |
Source: SEC Form 4 filings · as of 2026-07-27